AFINITOR® (everolimus) for Neuroendocrine Tumors of the Pancreas

This slideshow reviews drug information for AFINITOR® (everolimus) for neuroendocrine tumors of the pancreas.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 10: Use in Specific Populations
Slide 12: Clinical Pharmacology
Slide 16: Warnings and Precautions
Slide 19: Clinical Safety and Efficacy
Slide 23: Drug Storage and Supply